0001493152-24-042460.txt : 20241025 0001493152-24-042460.hdr.sgml : 20241025 20241025084926 ACCESSION NUMBER: 0001493152-24-042460 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241025 DATE AS OF CHANGE: 20241025 EFFECTIVENESS DATE: 20241025 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shuttle Pharmaceuticals Holdings, Inc. CENTRAL INDEX KEY: 0001757499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-527799 FILM NUMBER: 241394409 BUSINESS ADDRESS: STREET 1: 401 PROFESSIONAL DRIVE STREET 2: SUITE 260 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: (240) 403-4212 MAIL ADDRESS: STREET 1: 401 PROFESSIONAL DRIVE STREET 2: SUITE 260 CITY: GAITHERSBURG STATE: MD ZIP: 20879 D 1 primary_doc.xml X0708 D LIVE 0001757499 Shuttle Pharmaceuticals Holdings, Inc. 401 PROFESSIONAL DRIVE, SUITE 260 GAITHERSBURG MD MARYLAND 20879 240-403-4212 DELAWARE Shuttle Pharma Acquisition Corp., Inc. None Corporation true Anatoly Dritschilo c/o Shuttle Pharmaceuticals 401 Professional Drive, suite 260 Gaithersburg MD MARYLAND 20879 Executive Officer Director Chief Executive Officer and Chairman Peter Dritschilo c/o Shuttle Pharmaceuticals 401 Professional Drive, Suite 260 Gaithersburg MD MARYLAND 208579 Executive Officer President and Chief Operating Officer Mira Jung c/o Shuttle Pharmaceuticals 401 Professional Drive, Suite 260 Gaithersburg MD MARYLAND 20879 Executive Officer Chief Scientific Officer for Biology Tyvin Rich c/o Shuttle Pharmaceuticals 401 Professional Drive, Suite 260 Gaithersburg MD MARYLAND 20879 Executive Officer Chief Medical Officer Michael Vander Hoek c/o Shuttle Pharmaceuticals 401 Professional Drive, Suite 260 Gaithersburg MD MARYLAND 20879 Executive Officer Vice President - Operations and Regulatory Timothy Lorber c/o Shuttle Pharmaceuticals 401 Professional Drive, Suite 260 Gaithersburg MD MARYLAND 20879 Executive Officer Chief Financial Officer Milton Brown c/o Shuttle Pharmaceuticals 401 Professional Drive, Suite 260 Gaithersburg MD MARYLAND 20879 Director Steven Richards c/o Shuttle Pharmaceuticals 401 Professional Drive, Suite 260 Gaithersburg MD MARYLAND 20879 Director Bette Jacobs c/o Shuttle Pharmaceuticals 401 Professional Drive, Suite 260 Gaithersburg MD MARYLAND 20879 Director Chris Senanayake c/o Shuttle Pharmaceuticals 401 Professional Drive, Suite 260 Gaithersburg MD MARYLAND 20879 Director Joshua Schafer c/o Shuttle Pharmaceuticals 401 Professional Drive, Suite 260 Gaithersburg MD MARYLAND 20879 Director Pharmaceuticals Decline to Disclose 06b false 2024-10-14 false true true Convertible Note and Warrant to Purchase Common Stock false 95000 1300000 790000 510000 The issuer sold a total of $831,579 in 5% OID senior secured convertible notes and warrants to purchase 329,460 shares of common stock., exercisable at 125% of the closing price on the day prior to closing, for gross proceeds of $790,000. false 5 0 0 0 true false Shuttle Pharmaceuticals Holdings, Inc. /s/ Anatoly Dritschilo Anatoly Dritschilo Chief Executive Officer 2024-10-25